Nexstim

Third party research09.10.2026, 09.37

Nexstim: Conference feedback: Brainlab is set to scale NBS systems - NuWays AG Research

Paris MidCap conference feedback: Brainlab has the strategic fit and the installed base, to significantly scale Nexstim's NBS systems. Estimates unchanged. We remain with BUY and a PT of € 12.

Nexstim

Regulatory press release02.10.2026, 13.00

Nexstim Plc: Managers’ Transactions, Laine

Nexstim

Press release04.09.2026, 08.00

European University Hospital Orders Nexstim NBS 6 System

Nexstim

Press release03.09.2026, 08.00

Nordic Private Clinic Expands Use with Additional NBS 6 System

Nexstim

Third party research02.09.2026, 08.11

Nexstim: Stimulating growth with surgical accuracy; INITIATE with BUY - NuWays AG Research

Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magneticstimulation (nTMS) technology. With nTMS, Nexstim helps (i) surgeons preserve patients' motor and speech cortices and (ii) clinicians treat neurological and psychiatric...

Nexstim

Press release02.09.2026, 08.00